Investigating protein aggregation in neurodegenerative diseases like Alzheimer's and Parkinson's
Studying Aggregation in Neurodegenerative Disease using Synthetic Proteins
This study is looking at how certain proteins can misfold and clump together in diseases like Alzheimer's and Parkinson's, with the goal of finding new ways to help diagnose and treat these conditions so that patients can maintain their memory and quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10735475 on NIH RePORTER |
What this research studies
This research focuses on understanding how proteins misfold and aggregate in neurodegenerative diseases such as Alzheimer's and Parkinson's. By studying the accumulation of specific proteins, the research aims to identify potential drug targets that could reverse or block these aggregation processes. The approach involves examining how these aggregates propagate between neurons, which is crucial for developing effective diagnostic and therapeutic strategies. Patients may benefit from advancements in early diagnosis and treatment options that preserve cognitive functions and quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease, Parkinson's disease, or related neurodegenerative conditions.
Not a fit: Patients with neurodegenerative diseases not related to protein aggregation, or those in very advanced stages of these diseases, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that halt or reverse the progression of neurodegenerative diseases, improving patients' cognitive functions and overall quality of life.
How similar studies have performed: Previous research has shown promise in targeting protein aggregation in neurodegenerative diseases, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Petersson, Ernest James — University of Pennsylvania
- Study coordinator: Petersson, Ernest James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.